Minimal change nephrotic syndrome four days after the administration of Pfizer‐BioNTech COVID‐19 vaccine—a new side effect or coincidence?
Abstract The association between the COVID vaccine and MCD is temporal and by exclusion, and it is not fully established, but it should be considered in postvvaccine MCD.
Guardado en:
Autores principales: | Mohammed Abdulgayoom, Mhd Kutaiba Albuni, Elabbass Abdelmahmuod, Khaled Murshed, Yassir Eldeeb |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/273818cb5a9642beb3a4a87b70229aed |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy of Pfizer-BioNTech in SARS-CoV-2 Delta cluster
por: Hannah E. Landsberg, MSN, MPH, et al.
Publicado: (2022) -
Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers
por: Rami Alqassieh, et al.
Publicado: (2021) -
Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12–18 Years in Saudi Arabia
por: Edrous Alamer, et al.
Publicado: (2021) -
Nephrotic syndrome after treatment of Crohn′s disease with mesalamine: Case report and literature review
por: Belal M Firwana, et al.
Publicado: (2012) -
Neutrophilic urticarial dermatosis following BNT162b2 (Pfizer–BioNTech) COVID‐19 vaccination
por: Akihiro Matsubara, et al.
Publicado: (2021)